TriSalus Life Sciences Inc. (TLSI)
NASDAQ · Healthcare
TriSalus Life Sciences Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- TriSalus Life Sciences Inc. shareholder equity for the quarter ending December 31, 2025 were -33.9M, a 30.77% increase year-over-year.
- TriSalus Life Sciences Inc. shareholder equity for 2025 were -33.9M, a 30.77% increase from 2024.
- TriSalus Life Sciences Inc. shareholder equity for 2024 were -25.9M, a 4.33% decrease from 2023.
- TriSalus Life Sciences Inc. shareholder equity for 2023 were -27.1M, a 84.72% decrease from 2022.
- TriSalus Life Sciences Inc. shareholder equity for 2022 were -177.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| TriSalus Life Sciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-34 |
| 2024 | $-26 |
| 2023 | $-27 |
| 2022 | $-177 |
| TriSalus Life Sciences Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-34 |
| 2024-12-31 | $-26 |
| 2023-12-31 | $-27 |
| 2022-12-31 | $-177 |
TriSalus Life Sciences Inc. Shareholder Equity — FAQ
TriSalus Life Sciences Inc. (TLSI) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TLSI's shareholder equity history?
The chart and table above show TriSalus Life Sciences Inc.'s shareholder equity by year and by quarter, including the growth rate.